Life360, Inc. — Director's Dealing 2021

Jun 28, 2021

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: Life360, Inc.

ARBN: 629 412 942

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the followingthe director for the purposes of section	information under listing rule 3.19A.2 and as agent for205G of the Corporations Act.
Name of Director	Christopher (Chris) Hulls
Date of last notice	15 June 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct Interest
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	N/A
Date of change	25 June 2021 (PDT)
No. of securities held prior to change	8,659,656CHESSDepositaryInterests (CDIs)23,736 Shares of Common Stock(Shares)(equivalent to 71,208 CDIs)1,808,383OptionsoverShares(Options)63,362 Restricted Stock Units (RSUs)29,960 Shares (equivalent to 89,880CDIs)held byICCA Labs,LLC1
Class	Shares and CDIs
Number acquired	1,200,000 Shares

1 Chris Hulls is a member of ICCA Labs, LLC, an entity that holds Life360 shares. The number of shares attributable to Chris Hulls by reason of his membership interest in ICCA Labs, LLC is 29,960.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed	3,600,000 CDIs	3,600,000 CDIs
Value/Consideration	Nil.	CDIs were converted to Shares – no
Note: If consideration is non‐cash, provide details and estimatedvaluation	change in net holding and consideration
	required for conversions
No. of securities held after change		5,059,656 CDIs
		1,223,736Shares	(equivalent	to
		3,671,208 CDIs)
		1,808,383 Options
		63,362 RSUs
		29,960 Shares (equivalent to 89,880
		CDIs) held by ICCA	Labs, LLC
Nature of change	Conversion/transmutation of 3,600,000
Example: on‐market trade, off‐market trade, exercise of options,issue of securities under dividend reinvestment plan, participation in	CDIs to 1,200,000 Shares
buy‐back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	A$10.5 million personal loan facility (Loan).
Nature of interest	854,701 Shares (Pledged Shares) (equivalent to
	2,564,103 CDIs) pledged as security for the Loan.
	Chris Hulls will retain legal title to the Pledged
	Shares.
	Unless earlier repaid, on the Loan maturity date
	Chris Hulls is required to deliver to the lender a
	number of Shares and/or CDIs which is the lesser of
	i) Shares and/or CDIs with a market value which
	represents the amount outstanding under the Loan;
	and ii) the Pledged Shares. Chris Hulls may repay
	the Loan in cash on the maturity date with the
	consent of the lender.
Name of registered holder	N/A
(if issued securities)
Date of change	29 June 2021
No. and class of securities to which	N/A
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest acquired	N/A
Interest disposed	Up to 854,701 Shares (equivalent to 2,564,103 CDIs).
Value/ConsiderationNote: If consideration is non‐cash, provide detailsand an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	No.
If so, was prior written clearance provided to allow the tradeto proceed during this period?	N/A
If prior written clearance was provided, on what date was thisprovided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3